Dariclox® Intramammary Antibiotic
Features and Benefits
...Tube tip length, antibiotic efficacy, and milk withhold period impact your bottom line
Available in short tip tubes.
Demonstrated 77% cure rate for Streptococcus agalactiae in study of antibiotic treatments. 1
Effective against mastitis caused by nonpenicillinase-producing Staphylococcus aureus.
Quickly achieves high therapeutic levels, with proven antibacterial action for rapid effect.
One of the highest cure rates for Strep. agalactiae and one of the shortest milk withhold periods – 48 hours.
1 Wilson, DJ et al. 1999. Comparison of seven antiobiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens. J Dairy Sci 82:1664-1670.
DARICLOX is indicated in the treatment of bovine mastitis in lactating cows due to Streptococcus agalactiae and nonpenicillinase-producing Staphylococcus aureus.
Clinical experience indicates that antibiotic efficacy in the treatment of mastitis in lactating cows is directly related to the duration of infection. Therefore, treatment should be instituted as early as possible after detection.
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
Dariclox® Intramammary Antibiotic is a registered trademark of Schering-Plough Animal Health Corporation.
Product Label(s) and MSDS